N-{1-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332116552 (In-Stock Building Blocks)
- IUPAC Name
- N-{1-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide
- Mol formula
- C12H12ClN3O3S
- Mol weight
- 314 Da
- Catalog Number(s)
- BBLS21332116552, EN300-54826543, bbls21332116552
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.74
- Heavy atoms count
- 20
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.166
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-{1-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide (C12H12ClN3O3S) - CSSB21332116552](/st/structure/200/447a0366856bf4896216748a0cde3a74/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png "C12H12ClN3O3S")
- Zoom the structure
- CSSB21332116552
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-{1-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332124882](/st/structure/200/c5089eb1ece95336016f5aa56aac7384/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DC%2528F%2529C%253DC1.png)
![Chemical structure of N-[(1R)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332048415](/st/structure/200/63c573793ae84bd94dec502ed1eaf6fd/C%255BC%2540%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(1S)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332097262](/st/structure/200/58e976d7c50b8004cb0f2927910164d3/C%255BC%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-{1-[3-(4-ethylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332126595](/st/structure/200/a61b5539c20038ebb44e655e20554740/CCC1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%2528%253DN1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-{1-[3-(4-fluoro-3-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332053222](/st/structure/200/6fd37c1a8246e4f54a0c4792cc4096a7/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%2528C%2529%253DC%2528F%2529C%253DC1.png)
![Chemical structure of N-{1-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332117392](/st/structure/200/b8dc2376bfd666bc9b1e7783fb2794d7/COC1%253DCC%253DCC%2528%253DC1%2529C1%253DNOC%2528%253DN1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-{2-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332124092](/st/structure/200/60e22a5ba512e7c8741ab0cc39e7abfb/ClC1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%2528CCNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DN1.png)
